MFDS Approves Adjunctive Device for Blood Pressure Control in Patients Unresponsive to Medication

The Ministry of Food and Drug Safety announced on June 5 that it has approved a newly developed medical device: an ultrasonic surgical instrument for renal nerve ablation. This device is used as an adjunct to lower blood pressure in patients with hypertension whose blood pressure is not controlled despite lifestyle changes and taking antihypertensive medication.


Ultrasonic Surgical Device for Renal Nerve Ablation Approved for Hypertension Patients View original image

This device, imported by Otsuka Pharmaceutical Korea, involves inserting a thin catheter through the femoral artery. The heat generated by the ultrasound energy from the transducer mounted inside the catheter is used to disrupt the activity of the sympathetic nerves surrounding the renal arteries.


In clinical trials demonstrating the product's safety and efficacy, the use of this device resulted in a significant reduction in systolic blood pressure among patients with hypertension.


A newly developed medical device refers to a device that is completely new in at least one aspect, such as its mechanism of action, raw materials, method of use, performance, or intended purpose, compared to existing products.



The Ministry of Food and Drug Safety stated, "We will continue to provide diagnostic and treatment opportunities to more patients through prompt and fair medical device approval and review processes, and ensure people can enjoy healthy lives by using high-quality medical devices."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing